Study Site — Birmingham, Alabama

Study Site is a clinical research site located in Birmingham, Alabama, United States 35235.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Study Site has participated in 10 clinical trials with 2 currently active.

Therapeutic areas: Type 2 Diabetes, Hereditary Angioedema, Hereditary Angioedema Type I.

Sponsors: Intarcia Therapeutics, Pharvaris Netherlands B.V., CSL Behring.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 10 clinical trials on record, with 2 currently active. Their work covers Type 2 Diabetes, Hereditary Angioedema, Hereditary Angioedema Type I.

Is Study Site accredited by Crixeo Clinical Trials?

Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.